However, pre-op EGFR positivity and higher (≥2) pre-op EGFR scores were associated with shorter survival, albeit without statistical significance (p>0.05), supporting the previous studies which demonstrated that EGFR expression is associated with worse prognosis in patients receiving NCRT for locally advanced rectal cancer [8, 19]. This evidence concerns the gene EGFR and rectal cancer.